One patient died due to an unknown cause, possibly due to underlying medical conditions of hypertension and thrombosis; this fatal SAE was assessed by the investigators as not causally related to WT1-immunotherapeutic administration. This evidence concerns the gene WT1 and deep vein thrombosis.